- Home
- CDNA vs NMM Comparison
CDNA vs NMM Comparison
Compare CDNA & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- NMM
- Stock Information
- Founded
- CDNA 1998
- NMM 2007
- Country
- CDNA United States
- NMM Monaco
- Employees
- CDNA N/A
- NMM N/A
- Industry
- CDNA Medical Specialities
- NMM Marine Transportation
- Sector
- CDNA Health Care
- NMM Consumer Discretionary
- Exchange
- CDNA Nasdaq
- NMM Nasdaq
- Market Cap
- CDNA 1.1B
- NMM 1.3B
- IPO Year
- CDNA 2014
- NMM 2007
- Fundamental
- Price
- CDNA $18.92
- NMM $39.66
- Analyst Decision
- CDNA Buy
- NMM Strong Buy
- Analyst Count
- CDNA 8
- NMM 1
- Target Price
- CDNA $29.43
- NMM $80.00
- AVG Volume (30 Days)
- CDNA 912.4K
- NMM 96.5K
- Earning Date
- CDNA 05-08-2025
- NMM 02-13-2025
- Dividend Yield
- CDNA N/A
- NMM 0.51%
- EPS Growth
- CDNA N/A
- NMM N/A
- EPS
- CDNA 0.93
- NMM 12.15
- Revenue
- CDNA $333,785,000.00
- NMM $1,334,066,000.00
- Revenue This Year
- CDNA $13.32
- NMM N/A
- Revenue Next Year
- CDNA $14.99
- NMM $6.96
- P/E Ratio
- CDNA $20.44
- NMM $3.17
- Revenue Growth
- CDNA 19.07
- NMM 2.08
- 52 Week Low
- CDNA $7.42
- NMM $37.75
- 52 Week High
- CDNA $34.84
- NMM $65.89
- Technical
- Relative Strength Index (RSI)
- CDNA 36.93
- NMM 38.60
- Support Level
- CDNA $17.73
- NMM $37.75
- Resistance Level
- CDNA $22.61
- NMM $41.20
- Average True Range (ATR)
- CDNA 1.31
- NMM 1.45
- MACD
- CDNA -0.35
- NMM -0.26
- Stochastic Oscillator
- CDNA 18.97
- NMM 25.67
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through chartering of vessels, voyage contracts. Geographically, it generates majority revenue from Asia.